Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brian N. Cherry currently holds 166,486 shares of Atara Biotherapeutics, Inc. (ATRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian N. Cherry has been a net buyer of ATRA stock. They have purchased $1000.0K and sold $0 worth of shares.
Brian N. Cherry's most recent insider trade was on Sep 4, 2026, when they purchased 104,166 shares at $9.60 per share.
Brian N. Cherry serves as Executive at Atara Biotherapeutics, Inc. (ATRA). They have executed 2 insider transactions totaling $1000.0K over their tenure at the company.
Brian N. Cherry holds the position of Executive at Atara Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Brian N. Cherry has shown a buying trading pattern, with $1000.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Brian N. Cherry was on Sep 4, 2026, when they purchased $1000.0K worth of ATRA shares. This transaction involved 104,166 shares at $9.60 per share.
Brian N. Cherry currently owns 166,486 shares of Atara Biotherapeutics, Inc. (ATRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brian N. Cherry's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brian N. Cherry has 2 Form 4 filings on record as an insider at Atara Biotherapeutics, Inc..
Set alerts for Brian N. Cherry and 40,000+ other insiders.